Inventor · disambiguated record
Thomas J. Lobl
Also filed as: LOBL THOMAS · LOBL THOMAS J · LOBL THOMAS JAY
26 granted patents·13 pending applications·1,017 citations·filing 1978–2021
97Inventor score
Top patents by PatentIndex Score
39 records- 0198US7498302B2Disulfide prodrugs and linkers and stabilizers useful thereforMEDAREX INC·Filed 2005·Granted Mar 3, 2009·123 cites·32 claims
- 0298US6989452B2Disulfide prodrugs and linkers and stabilizers useful thereforMEDAREX INC·Filed 2002·Granted Jan 24, 2006·284 cites·21 claims
- 0397US8034959B2Methods of treating cancer with an antibody-drug conjugateMEDAREX INC·Filed 2009·Granted Oct 11, 2011·37 cites·19 claims
- 0494US7329507B2Prodrug compounds with isoleucineMEDAREX INC·Filed 2006·Granted Feb 12, 2008·27 cites·5 claims
- 0594US7115573B2Prodrug compounds with an isoleucineMEDAREX INC·Filed 2001·Granted Oct 3, 2006·61 cites·41 claims
- 0693US7214663B2Tripeptide prodrug compoundsMEDAREX INC·Filed 2001·Granted May 8, 2007·52 cites·26 claims
- 0792US5192746ACyclic cell adhesion modulation compoundsTANABE SEIYAKU CO·Filed 1990·Granted Mar 9, 1993·145 cites·15 claims
- 0891US7425541B2Enzyme-cleavable prodrug compoundsMEDAREX INC·Filed 2001·Granted Sep 16, 2008·37 cites·23 claims
- 0990US8034787B2Enzyme-cleavable prodrug compoundsMEDAREX INC·Filed 2008·Granted Oct 11, 2011·8 cites·17 claims
- 1089US7816317B2Tripeptide prodrug compoundsMEDAREX INC·Filed 2007·Granted Oct 19, 2010·13 cites·26 claims
- 1187US7696313B2Prodrug compounds with isoleucineMEDAREX INC·Filed 2008·Granted Apr 13, 2010·7 cites·10 claims
- 1284US6596752B1Inhibitors of α4β1 mediated cell adhesionTANABE SEIYAKU CO·Filed 2002·Granted Jul 22, 2003·15 cites·15 claims
- 1384US5210075AInterleukin 6 antagonist peptidesTANABE SEIYAKU CO·Filed 1990·Granted May 11, 1993·95 cites·15 claims
- 1483US4297350AMale contraceptive steroids and methods of useUPJOHN CO·Filed 1978·Granted Oct 27, 1981·17 cites·17 claims
- 1577US6685617B1Inhibitors of α4β1 mediated cell adhesionUPJOHN CO·Filed 1999·Granted Feb 3, 2004·24 cites·9 claims
- 1674US8771746B2Colloidal suspensions comprising a therapeutic agent and squaleneSCHLOSS JOHN VINTON·Filed 2009·Granted Jul 8, 2014·1 cites·3 claims
- 1772US6482849B1Inhibitors of α4β1 mediated cell adhesionTANABE SEIYAKU CO·Filed 1998·Granted Nov 19, 2002·13 cites·17 claims
- 1869US8267905B2Apparatus and method for delivery of therapeutic and other types of agentsLOBL THOMAS J·Filed 2006·Granted Sep 18, 2012·13 cites·10 claims
- 1965US11890112B2Skull-mounted drug and pressure sensorCOGNOS THERAPEUTICS INC·Filed 2020·Granted Feb 6, 2024·0 cites·3 claims
- 2065US11890111B2Skull-mounted drug and pressure sensorCOGNOS THERAPEUTICS INC·Filed 2020·Granted Feb 6, 2024·0 cites·5 claims
- 2165US7803148B2Flow-induced delivery from a drug massNEUROSYSTEC CORP·Filed 2007·Granted Sep 28, 2010·9 cites·20 claims
- 2264US11883203B2Skull-mounted drug and pressure sensorCOGNOS THERAPEUTICS INC·Filed 2020·Granted Jan 30, 2024·0 cites·3 claims
- 2360US8298176B2Flow-induced delivery from a drug massLOBL THOMAS J·Filed 2010·Granted Oct 30, 2012·2 cites·11 claims
- 2457US5821329ACyclic peptide inhibitors of β1 and β2 integrin-mediated adhesionTANABE SEIYAKU CO·Filed 1996·Granted Oct 13, 1998·21 cites·45 claims
- 2555US10786155B2Skull-mounted drug and pressure sensorCOGNOS THERAPEUTICS INC·Filed 2017·Granted Sep 29, 2020·0 cites·12 claims
- 2654US2023191095A1Inline Pressure and Temperature Sensor for Cerebral ShuntsCOGNOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2752US2012208848A1Gacyclidine formulationsLOBL THOMAS JAY·Filed 2012·Application pending·0 cites
- 2851US2021121624A1Implantable infusion devices with closed loop sensing and associated methodsTHE ALFRED E MANN FOUNDATION FOR SCIENT RESEARCH·Filed 2020·Application pending·0 cites
- 2949US2006205789A1Gacyclidine formulationsNEUROSYSTEC CORP·Filed 2006·Application pending·0 cites
- 3048US5721210ACyclic cell adhesion modulation compoundsTANABE SEIYAKU CO·Filed 1995·Granted Feb 24, 1998·13 cites·17 claims
- 3145US2009209945A1Valveless impedance pump drug delivery systemsNEUROSYSTEC CORP·Filed 2009·Application pending·0 cites
- 3244US2011136870A1Gacyclidine formulationsNEUROSYSTEC CORP·Filed 2011·Application pending·0 cites
- 3343US2011077579A1Cochlear implant with localized fluid transportHARRISON WILLIAM V·Filed 2006·Application pending·0 cites
- 3441US2008065002A1Catheter for Localized Drug Delivery and/or Electrical StimulationNEUROSYSTEC CORP·Filed 2007·Application pending·0 cites
- 3541US2008152694A1Devices, Systems and Methods for Ophthalmic Drug DeliveryNEUROSYSTEC CORP·Filed 2007·Application pending·0 cites
- 3641US2008145439A1Nanoparticle drug formulationsNEUROSYSTEC CORP·Filed 2007·Application pending·0 cites
- 3738US2002115642A1Beta-lactam antibioticsFiled 2001·Application pending·0 cites
- 3837US2006264897A1Apparatus and method for delivering therapeutic and/or other agents to the inner ear and to other tissuesNEUROSYSTEC CORP·Filed 2006·Application pending·0 cites
- 3936US2010305551A1Valveless Impedance Pump Drug Delivery SystemsNEUROSYSTEC CORP·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas J. Lobl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →